Alzheimer’s is the only major disease yet to be conquered, and is the leading cause of dementia, the seventh leading cause of death in the world.
Tag: JNJ
Why Eli Lilly become global pharmaceutical market value king?
It is recommended that you also read my previous post related to Eli Lilly (ticker: LLY): Two future star drugs in hand Because it holds two future star drugs, Eli Lilly is very likely to become the world’s first listed pharmaceutical company with a market value of more than one trillion US dollars! With Alzheimer’s … Continue reading “Why Eli Lilly become global pharmaceutical market value king?”
Intuitive Surgical, a company that essentially monopolizes surgical robots
Da Vinci medical surgical robot is now more famous than Intuitive Surgical, it is not regulated, but it is a real monopoly
Novo Nordisk’s new diabetes drug Semaglutide,Ozempic,Wegovy and Incretin found to have surprising weight-loss effects
Novo Nordisk is one of the world’s major pharmaceutical companies supplying insulin for the treatment of diabetes, and insulin is its main business.
Big pharma spin-offs, and advantages to invest them
The following are the three big pharma spin-offs I know of in the past ten years. These three pharmaceutical companies are all world-renowned super pharmaceutical companies
The next No. 1 pharmaceutical leader AbbVie
AbbVie’s (ticker: ABBV) parent company, Abbott (ticker: ABT), was founded in 1888 by Wallace C. Abbott.
Cardiac device maker Abiomed acquired by Johnson & Johnson
In section 3-4, page 152 of my book “The Rules of 10 Baggers”, when I discuss the rising star of medical equipment, I use the company ABIOMED as an example.
Why Shopify is so killing?
Readers are interested in Shopify
How the best AAA credit rating Johnson & Johnson makes money?
Johnson & Johnson is a important US listed company
Stable Dow Component Merck, how does it make money?
Stable Dow Component Merck, Merck (ticker: MRK) Since the mid-20th century, Merck, a component of the Dow Jones Index, has been the top pharmaceutical company because Merck spends more on research and development than other companies.
